MX342938B - Composicion farmaceutica de fosfomicina. - Google Patents
Composicion farmaceutica de fosfomicina.Info
- Publication number
- MX342938B MX342938B MX2013007232A MX2013007232A MX342938B MX 342938 B MX342938 B MX 342938B MX 2013007232 A MX2013007232 A MX 2013007232A MX 2013007232 A MX2013007232 A MX 2013007232A MX 342938 B MX342938 B MX 342938B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- phosphomycin
- present
- composition
- phosphomycin pharmaceutical
- Prior art date
Links
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 239000004376 Sucralose Substances 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 238000012505 colouration Methods 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 abstract 1
- 235000019408 sucralose Nutrition 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
- 229960000281 trometamol Drugs 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica sólida de fosfomicina estable frente a la coloración, apta para diabéticos y que no causa problemas gastrointestinales. La composición farmacéutica de esta invención comprende fosfomicina trometamol, glicina, y opcionalmente otros excipientes como sucralosa, dióxido de silicio, polivinilpirrolidona y aroma; y está sustancialmente libre de azúcares y alcoholes de azúcar tales como sacarosa, fructosa, glucosa, xilitol, manitol, sorbitol o mezclas de éstos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201001613A ES2385158B1 (es) | 2010-12-24 | 2010-12-24 | Composición farmacéutica de fosfomicina |
| PCT/ES2011/000366 WO2012085304A1 (es) | 2010-12-24 | 2011-12-19 | Composición farmacéutica de fosfomicina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013007232A MX2013007232A (es) | 2013-08-15 |
| MX342938B true MX342938B (es) | 2016-10-19 |
Family
ID=46313210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013007232A MX342938B (es) | 2010-12-24 | 2011-12-19 | Composicion farmaceutica de fosfomicina. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2656846B1 (es) |
| JP (1) | JP6012622B2 (es) |
| KR (1) | KR20140091649A (es) |
| CN (1) | CN103282038B (es) |
| BR (1) | BR112013016029A2 (es) |
| CA (1) | CA2821382C (es) |
| DK (1) | DK2656846T3 (es) |
| EA (1) | EA023846B1 (es) |
| ES (2) | ES2385158B1 (es) |
| HK (1) | HK1188959A1 (es) |
| HU (1) | HUE027572T2 (es) |
| MX (1) | MX342938B (es) |
| PL (1) | PL2656846T3 (es) |
| PT (1) | PT2656846T (es) |
| WO (1) | WO2012085304A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017111718A1 (en) | 2015-12-25 | 2017-06-29 | Yusuf Toktamiş Öğün | The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections |
| CA3147662A1 (en) | 2021-02-10 | 2022-08-10 | Labiana Health, S.L. | New fosfomycin tablet formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1112282B (it) * | 1978-07-19 | 1986-01-13 | Zambon Spa | Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato |
| IT1231013B (it) | 1989-07-27 | 1991-11-08 | Zambon Spa | Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'. |
| ES2103682B1 (es) * | 1995-09-20 | 1998-04-01 | Lilly Sa | Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas. |
| ITMI20021725A1 (it) * | 2002-08-01 | 2002-10-31 | Zambon Spa | Composizioni farmaceutiche ad attivita' antibiotica. |
| ES2244333B1 (es) * | 2004-05-18 | 2006-08-01 | Simbec Iberica, Sl | Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos. |
-
2010
- 2010-12-24 ES ES201001613A patent/ES2385158B1/es active Active
-
2011
- 2011-12-19 PL PL11851679.8T patent/PL2656846T3/pl unknown
- 2011-12-19 HU HUE11851679A patent/HUE027572T2/en unknown
- 2011-12-19 ES ES11851679.8T patent/ES2574916T3/es active Active
- 2011-12-19 CN CN201180062697.XA patent/CN103282038B/zh not_active Expired - Fee Related
- 2011-12-19 JP JP2013545445A patent/JP6012622B2/ja not_active Expired - Fee Related
- 2011-12-19 EP EP11851679.8A patent/EP2656846B1/en active Active
- 2011-12-19 EA EA201390760A patent/EA023846B1/ru not_active IP Right Cessation
- 2011-12-19 MX MX2013007232A patent/MX342938B/es active IP Right Grant
- 2011-12-19 WO PCT/ES2011/000366 patent/WO2012085304A1/es active Application Filing
- 2011-12-19 DK DK11851679.8T patent/DK2656846T3/en active
- 2011-12-19 BR BR112013016029A patent/BR112013016029A2/pt not_active Application Discontinuation
- 2011-12-19 PT PT118516798T patent/PT2656846T/pt unknown
- 2011-12-19 KR KR1020137016662A patent/KR20140091649A/ko not_active Application Discontinuation
- 2011-12-19 CA CA2821382A patent/CA2821382C/en not_active Expired - Fee Related
-
2014
- 2014-03-04 HK HK14102180.0A patent/HK1188959A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2821382C (en) | 2019-01-08 |
| EP2656846A4 (en) | 2014-07-09 |
| CN103282038A (zh) | 2013-09-04 |
| CN103282038B (zh) | 2016-08-10 |
| EP2656846B1 (en) | 2016-03-30 |
| PL2656846T3 (pl) | 2016-09-30 |
| DK2656846T3 (en) | 2016-07-04 |
| BR112013016029A2 (pt) | 2017-06-13 |
| EP2656846A1 (en) | 2013-10-30 |
| KR20140091649A (ko) | 2014-07-22 |
| HK1188959A1 (zh) | 2014-05-23 |
| EA023846B1 (ru) | 2016-07-29 |
| MX2013007232A (es) | 2013-08-15 |
| ES2574916T3 (es) | 2016-06-23 |
| JP2014500301A (ja) | 2014-01-09 |
| JP6012622B2 (ja) | 2016-10-25 |
| EA201390760A1 (ru) | 2013-12-30 |
| PT2656846T (pt) | 2016-07-08 |
| HUE027572T2 (en) | 2016-10-28 |
| CA2821382A1 (en) | 2012-06-28 |
| WO2012085304A1 (es) | 2012-06-28 |
| ES2385158A1 (es) | 2012-07-19 |
| ES2385158B1 (es) | 2013-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2527654T3 (es) | Barquillo | |
| MX2012002749A (es) | Aumentadores de dulzura incluyendo rebaudiosido a o d. | |
| NZ603332A (en) | Sweet flavor modifier | |
| BR112012028618A2 (pt) | composição edulcorantes com reduzido sabor desagradável amargo e métodos de preparo | |
| MX2016007178A (es) | Glucosidos de triterpeno novedosos como edulcorantes o potenciadores de edulcorantes. | |
| PE20121517A1 (es) | Compuestos lipopeptidos y metodos relacionados | |
| WO2009102820A3 (en) | Modified sugar substrates and methods of use | |
| WO2011124953A3 (en) | Controlled release pharmaceutical compositions of tapentadol | |
| AR051048A1 (es) | Sustituto del azucar bajo en calorias o sin calorias, no higroscopico | |
| AR083480A1 (es) | Mezclas de stevia que contienen rebaudiosida b | |
| EP3329965A3 (en) | Dosing regimen of anti-alpha4beta7-antikörper | |
| BR112012021771A2 (pt) | métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2. | |
| PH12016500662A1 (en) | Reduced sugar frozen confection composition | |
| WO2014207770A3 (en) | A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same | |
| WO2012098522A3 (en) | Detergent composition including a saccharide or sugar alcohol | |
| WO2006120574A3 (en) | Analogs of 4-hydroxyisoleucine and uses thereof | |
| WO2011036521A3 (en) | Formulations comprising triptan compounds | |
| WO2012148252A3 (es) | Cocristales ionicos con base en metformina | |
| MX2013007232A (es) | Composicion farmaceutica de fosfomicina. | |
| WO2011025978A3 (en) | Methods of treatment using anti-oxidized ldl antibodies | |
| EA200900953A1 (ru) | Подщелачивание диффузионного сока | |
| ATE534382T1 (de) | Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon | |
| AR086794A1 (es) | Composicion farmaceutica de fosfomicina | |
| GR1007432B (el) | Σιροπι με γευση κακαο, χωρις σακχαρα, με χαμηλο γλυκαιμικο δεικτη, με φυτικες ινες | |
| TW200806195A (en) | Low calorific value eating sugar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |